# Clinical Study of Vitamin B5 in Adjuvant Treatment of IBD

> **NCT05701501** · NA · UNKNOWN · sponsor: **Changhai Hospital** · enrollment: 100 (estimated)

## Conditions studied

- Inflammatory Bowel Diseases

## Interventions

- **DRUG:** Vitamin B5 Tablets
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT05701501
- **Lead sponsor:** Changhai Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-02-01
- **Primary completion:** 2024-02-01
- **Final completion:** 2024-02-01
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2023-06-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05701501

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05701501, "Clinical Study of Vitamin B5 in Adjuvant Treatment of IBD". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05701501. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
